Abstract 67 TableĀ 1
EndpointsNon-Rapid CAV
(n=84)
Rapid CAV
(n=8)
P-Value
Subsequent 1-Year Actual Survival94.9%75.0%*0.025
Subsequent 1-Year Actual Freedom from NF-MACE88.0%87.5%0.970
Subsequent 1-Year Actual Freedom from de novo DSA100.0%100.0%1.000
  • *p<0.05 compared Non-Rapid CAV.